Related Experiment Video
Updated: Jul 13, 2025

08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
675
OffRisk: a docker image for annotating CRISPR off-target sites in the human genome
Gil-Ad Barkai1, Tal Malul1, Yossi Eliaz2,3,4
1Department of Software & Information Systems Engineering, Faculty of Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Bioinformatics Advances
|October 16, 2023
Summary
OffRisk is a new tool that helps scientists design better CRISPR-Cas9 guide RNAs (gRNAs). It identifies potential harmful off-target sites in the human genome, improving the safety of genome editing experiments.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- The CRISPR-Cas9 system enables targeted genome editing and transcriptional control via customizable guide RNAs (gRNAs).
- Off-target binding of gRNAs can lead to unintended genomic modifications with potentially harmful consequences.
- Accurate prediction and assessment of off-target sites are crucial for safe and effective CRISPR applications.
Purpose of the Study:
- To develop a computational tool, OffRisk, for identifying and evaluating off-target sites in the human genome.
- To assist researchers in designing safer and more specific guide RNAs for CRISPR-Cas9 applications.
- To integrate functional and regulatory genomic information for improved off-target risk assessment.
Main Methods:
- Development of OffRisk, a Docker-based bioinformatics tool.
- Annotation of potential off-target sites in the human genome.
- Integration of multi-level functional and regulatory genomic data to assign risk labels to off-target sites.
Main Results:
- OffRisk successfully annotates off-target sites within the human genome.
- The tool assigns a potential risk label to each off-target site based on integrated genomic information.
- This facilitates informed gRNA design by highlighting potentially problematic sequences.
Conclusions:
- OffRisk provides a valuable resource for improving the specificity and safety of CRISPR-Cas9 genome editing.
- The tool aids researchers in mitigating risks associated with unintended gRNA binding.
- OffRisk contributes to the advancement of reliable genome engineering technologies.
Related Concept Videos
CRISPR/Cas9 Genome Editing
24
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
24
CRISPR
52.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.1K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K

